- Home
- LPCN vs LEDS Comparison
LPCN vs LEDS Comparison
Compare LPCN & LEDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPCN
- LEDS
- Stock Information
- Founded
- LPCN 1997
- LEDS 2005
- Country
- LPCN United States
- LEDS Taiwan
- Employees
- LPCN N/A
- LEDS N/A
- Industry
- LPCN Biotechnology: Pharmaceutical Preparations
- LEDS Semiconductors
- Sector
- LPCN Health Care
- LEDS Technology
- Exchange
- LPCN Nasdaq
- LEDS Nasdaq
- Market Cap
- LPCN 16.1M
- LEDS 16.1M
- IPO Year
- LPCN N/A
- LEDS 2010
- Fundamental
- Price
- LPCN $2.99
- LEDS $2.13
- Analyst Decision
- LPCN Strong Buy
- LEDS
- Analyst Count
- LPCN 2
- LEDS 0
- Target Price
- LPCN $9.00
- LEDS N/A
- AVG Volume (30 Days)
- LPCN 16.6K
- LEDS 71.3K
- Earning Date
- LPCN 11-06-2025
- LEDS 07-11-2025
- Dividend Yield
- LPCN N/A
- LEDS N/A
- EPS Growth
- LPCN N/A
- LEDS N/A
- EPS
- LPCN N/A
- LEDS N/A
- Revenue
- LPCN $4,208,119.00
- LEDS $31,108,000.00
- Revenue This Year
- LPCN N/A
- LEDS N/A
- Revenue Next Year
- LPCN N/A
- LEDS N/A
- P/E Ratio
- LPCN N/A
- LEDS N/A
- Revenue Growth
- LPCN N/A
- LEDS 485.62
- 52 Week Low
- LPCN $2.68
- LEDS $0.92
- 52 Week High
- LPCN $6.17
- LEDS $3.16
- Technical
- Relative Strength Index (RSI)
- LPCN 50.61
- LEDS 62.12
- Support Level
- LPCN $2.85
- LEDS $1.81
- Resistance Level
- LPCN $3.08
- LEDS $2.16
- Average True Range (ATR)
- LPCN 0.09
- LEDS 0.19
- MACD
- LPCN 0.01
- LEDS 0.05
- Stochastic Oscillator
- LPCN 59.83
- LEDS 46.10
About LPCN Lipocine Inc.
Lipocine Inc is a clinical-stage biopharmaceutical company, that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing drugs. Lipocine develops its drug candidates or it develops drug candidates on behalf of or in collaboration with corporate partners. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, TLANDO, TLANDO XR, LPCN 1148, LPCN 1107, LPCN 1154, and LIP'RAL7 Technology. The Company has a single reportable segment, research, and development for the delivery of drugs using its proprietary delivery technology.
About LEDS SemiLEDS Corporation
SemiLEDs Corp develops, manufactures, and sells light-emitting diode chips and LED components. The company's products include LED Chips, LED Components, and Lighting Products. Its products are used for general lighting applications, including street lights and commercial, industrial, system, and residential lighting; specialty industrial applications, such as ultraviolet, or Ultraviolet, curing of polymers, LED light therapy in medical/cosmetic applications, counterfeit detection, LED lighting for horticulture applications, architectural lighting and entertainment lighting. Substantial revenue is generated from the sale of LED components products. Geographically, it derives a majority of its revenue from Japan.